Embecta (EMBC) Cash from Operations Growth (1y) (2021 - 2026)
Embecta (EMBC) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.09 Bn | 121.88 Bn | 1.96 Bn | 48.31% |
| 2 | Becton Dickinson | 44.79 Bn | 43.98 Bn | 2.15 Bn | 428.92% |
| 3 | Alcon | 33.02 Bn | 31.36 Bn | 1.53 Bn | - |
| 4 | Medline | 32.86 Bn | 30.62 Bn | 1.84 Bn | -39.59% |
| 5 | Resmed | 29.36 Bn | 27.70 Bn | 890.98 Mn | -4.24% |
| 6 | West Pharmaceutical Services | 23.26 Bn | 22.82 Bn | 329.20 Mn | -29.98% |
| 7 | Solventum | 14.09 Bn | 13.53 Bn | 1.10 Bn | -751.72% |
| 8 | Cooper Companies | 13.78 Bn | 13.64 Bn | 735.40 Mn | 90.02% |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn | 186.74% |
| 10 | Embecta | 204.58 Mn | 11.18 Mn | 127.80 Mn | -2.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.20% |
| Dec 31, 2025 | 424.53% |
| Sep 30, 2025 | 215.79% |
| Jun 30, 2025 | 3,966.67% |
| Mar 31, 2025 | 30.86% |
| Dec 31, 2024 | 59.54% |
| Sep 30, 2024 | -10.14% |
| Jun 30, 2024 | 77.42% |
| Mar 31, 2024 | 286.92% |
| Dec 31, 2023 | -121.69% |
| Sep 30, 2023 | -48.97% |
| Jun 30, 2023 | -128.35% |
| Mar 31, 2023 | -107.12% |
| Dec 31, 2022 | -56.48% |
| Sep 30, 2022 | -32.16% |
| Jun 30, 2022 | -74.71% |
| Mar 31, 2022 | 52.55% |
| Dec 31, 2021 | 14.33% |